EncephalX
5 known investors
Find your way into EncephalX
57 people in our graph share verified history with the EncephalX team — schools, employers, funds. One of them is your warm intro.
Henri Arslanianunlockedknows Simon Lapointe · together at Université de Sherbrooke
×11knows the team · via Université de Sherbrooke
EncephalX develops the Dynamic Cranioplasty System (DCPS), a cranial implant that treats traumatic brain injuries and strokes in a single procedure rather than the conventional two surgeries. The device targets neurosurgery care for patients requiring intracranial decompression, positioned in the medical device industry.
Founders & leadership
SL
Simon LapointeinCEO & FounderSimon Lapointe holds a degree in bioengineering and founded EncephalX in 2020 to develop medical devices for neurosurgery, specifically addressing intracranial hypertension following traumatic brain injury and stroke.
DC
Dr Christian Iorio-MorinCMO & Neurosurgeon
LR
Louis-Philippe RielinCTO
Investors · 5
Front Row VenturesMontreal
ACET CapitalreportedSherbrooke
Anges QuébecreportedMontreal
HaloHealthreportedToronto
Also in the syndicate · 1
Investissement Québec
Funding
SEC filings, press & company announcements- Undisclosed amountpre-seed roundFeb 2026
ACET Capital (lead), Anges Québec, HaloHealth, Investissement Québec
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does EncephalX do?
- EncephalX develops the Dynamic Cranioplasty System (DCPS), a cranial implant that treats traumatic brain injuries and strokes in a single procedure rather than the conventional two surgeries. The device targets neurosurgery care for patients requiring intracranial decompression, positioned in the medical device industry.
- Who founded EncephalX?
- EncephalX was founded by Simon Lapointe.
- Who are EncephalX's investors?
- EncephalX's investors include Front Row Ventures, ACET Capital, Anges Québec, HaloHealth.